Parameters |
MIP-1a expression* |
CD68+TAM count
(/x400 field) |
CD105- MVD (/x200 field) |
|
"r" value |
Pvalue |
"r" value |
P
value |
"r" value |
Pvalue |
Serum AST (U/L) |
0.221 |
0.428 |
0.301 |
0.275 |
0.289 |
0.296 |
Serum ALT (U/L) |
0.333 |
0.225 |
0.348 |
0.204 |
0.303 |
0.273 |
Serum GGT (U/L) |
0.126 |
0.655 |
0.149 |
0.596 |
0.121 |
0.666 |
Serum AFP (ng/ml) |
0.489 |
0.065 |
0.279 |
0.314 |
0.276 |
0.320 |
Child-Pugh score* |
0.326 |
0.236 |
0.133 |
0.637 |
0.175 |
0.533 |
MELD score* |
0.260 |
0.349 |
0.196 |
0.484 |
0.317 |
0.249 |
Serum MIP-1a (pg/ml) |
0.671 |
0.006 |
0.410 |
0.129 |
0.401 |
0.138 |
HCC diameter (cm) |
0.730 |
0.002 |
0.642 |
0.010 |
0.641 |
0.010 |
CLIP stage* |
0.637 |
0.011 |
0.602 |
0.018 |
0.625 |
0.013 |
HCC grade* |
0.728 |
0.002 |
0.838 |
<0.001 |
0.762 |
0.001 |
HAI grade |
-0.314 |
0.255 |
-0.206 |
0.461 |
-0.165 |
0.556 |
Steatosis* |
-0.203 |
0.468 |
-0.224 |
0.422 |
-0.175 |
0.533 |
CD68+ TAM count |
0.844 |
<0.001 |
- |
- |
- |
- |
CD105-MVD |
0.615 |
0.015 |
0.917 |
<0.001 |
- |
- |
AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; GGT: Gamma glutamyl transpeptidase; AFP :Alpha-fetoprotein; MELD: Model for End-stage Liver Disease; MIP-1α: Macrophage Inflammatory Protein-1α; CLIP: Cancer of the Liver Italian Program; HAI: Histological Activity Index.
*Spearman’s rank test |